Introduction: This study seeks to evaluate the incidence and associated risk factors for
Introduction
In the United States, Clostridium difficile, a spore-forming, gram-positive anaerobic bacillus, is the leading cause of nosocomial infectious diarrhea. 1 Despite efforts on infection control and prudent antibiotic stewardship, the incidence of Clostridium difficile infection (CDI)
continues to escalate in both the nosocomial and community settings. 2, 3 Since the emergence of the hypervirulent NAP1/027 strain in recent years, there has been an increase in the severity of CDI, with more patients failing medical therapy and requiring emergent colectomy. 2, 4, 5 Recent epidemiologic data suggests that CDI is a growing burden among surgical patients and is associated with increased morbidity, mortality, hospital stay and health care costs. 6, 7 The risk of CDI is highest among patients requiring intestinal tract manipulation or reconstruction, a population very similar to patients undergoing radical cystectomy (RC). 6 Other major risk factors for CDI include advanced age and recent antibiotic exposure. 4, [8] [9] [10] Bladder cancer patients tend to be older and require frequent antimicrobial prophylaxis for pre-and perioperative urinary tract instrumentation, therefore placing them at a higher risk for development of CDI.
Recent studies utilizing data from community practice settings identified a CDI rate of 1.3 -1.7% in patients undergoing RC. 10, 11 However, with RC becoming more regionalized to tertiary referral centers, 12 the complications and incidence associated with CDI after RC at referral centers are rarely reported. The purpose of this study is two-fold: to determine the incidence of CDI in a contemporary cohort undergoing RC at a high-volume tertiary referral center, and to identify the perioperative risk factors for development CDI in RC patients.
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Materials and Methods
Following institutional review board approval, we conducted a retrospective review of patients undergoing RC between January 2010 and December 2013 at our institution for bladder The primary end point of this study was the development of CDI within 90 days of RC.
CDI was diagnosed by detection of the Clostridium difficile toxin B gene using polymerase chain reaction based stool assay in patients with clinically significant diarrhea, which is defined as greater than three loose bowel movements in one day, or presence of pseudomembranous colitis 
Results
Of the 552 patients who underwent RC at our institution, 49 (8.8%) patients developed CDI. The rate of CDI in RC patients increased from 6.4 per 1000 patients in 2010 to 16.5 per 1000 patients in 2013 ( Figure 1 ) and a small increase in hospital-wide CDI rate was also observed in the same time period (Table 1) . Of the 115 patients with clinically significant diarrhea, 42.6% tested positive for CDI. The number of patients presenting with clinically significant diarrhea also increased between 2010 and 2013 ( The most common initial presenting symptom of CDI was diarrhea in 48 patients (97.9%). Thirty-three patients (67.3%) were treated with either intravenous or oral metronidazole, and the remaining patients were treated with a combination of metronidazole and oral vancomycin. Two patients with severe CDI and a history of fecal diversion were treated with vancomycin lavage via their end colostomies.
In the stepwise logistic regression model, preoperative hemoglobin, chronic antacid therapy, perioperative antibiotic duration and urinary diversion type were considered significant (p<0.2), and therefore were included in the final multivariable logistic regression model.
Patients on chronic antacid therapy had a 1.9 times increased odds of CDI when adjusting for preoperative hemoglobin, urinary diversion type, and duration of perioperative antibiotics 8 received (p=0.04, Table 3 ). Additionally, patients who received more than 7 days of antibiotics (starting in the preoperative setting) had a 2.2 times increased odds of CDI when compared to patients who received no more than one day of antibiotics (p=0.02). Since only patients with an Indiana pouch received mechanical bowel preparation, urinary diversion type was not significantly associated with CDI. This suggests that mechanical bowel preparation is unlikely an inciting factor for CDI.
Patients with CDI were more likely to have a longer hospital stay and higher readmission rate ( 
Discussion
This study provides contemporary data on the incidence and risk factors associated with CDI in patients undergoing RC. At high-volume centers, the incidence of CDI in patients undergoing RC is largely unknown. In a recent review of 5,425 patients undergoing RC from more than 2,900 community hospitals, Calvert et al. identified a CDI incidence of 1.7%, which is higher than patients undergoing radical prostatectomy (0.02%) or nephrectomy (0.23%) but comparable to those undergoing colorectal procedures (1.5%). 10, 13 A retrospective review of 180
patients undergoing RC at a high-volume institution reported a higher CDI rate of 7.2% within 30 days of surgery. 14 Our study found that 8.8% of patients undergoing RC for bladder cancer developed CDI within 90 days of surgery. Additionally, we demonstrated that nearly 10% of patient readmissions for postoperative complications were related to CDI, emphasizing the significant morbidity associated with this disease.
Antimicrobial exposure is the most commonly cited risk factor for CDI development in surgical patients and the risk of CDI increases with longer duration of exposure. 4, 9, 15, 16 A recent study from the Netherlands showed that the risk of CDI development is the highest during therapy and in the first month following antibiotic use. 17 In congruence with these published findings, our study showed that the risk of CDI is highest after having received more than 7 days of perioperative antibiotics (HR: 2.2, p=0.02) compared to those who received only one day or less of antibiotics. Our findings highlight the importance of minimizing antimicrobial exposure in RC patients and should serve as an important reminder to follow appropriate prophylaxis guidelines.
Antibiotic stewardship programs have been shown to decrease overall CDI rates, 18, 19 but could a similar strategy be adopted in patients undergoing RC? For patients undergoing urinary diversions, the American Urological Association recommends the use of antimicrobial prophylaxis for no more than 24 hours after surgery. 20 Our study showed that only 49% of patients followed the appropriate guidelines on antimicrobial prophylaxis. While the compliance rate at our institution seems low, the study by Calvert et al. also showed a comparable compliance rate of 44% in RC patients. 10 Reasons for deviation from antimicrobial prophylaxis guidelines in RC patients include increased patient comorbidities, preoperative bacteriuria, difficult operations associated with fecal contamination, and indwelling hardware such as ureteral stents, catheters and/or surgical drains. 21 Limiting antibiotic use in the postoperative setting seems logical but is difficult to apply universally as the incidence of postoperative infectious complications after RC patients remains high, and is reported in 16% to 38% of patients. 22, 23 Limiting the use of preoperative antimicrobials in RC patients should be a priority.
Approximately 30% of patients in our series received antibiotics for bacteriuria identified on preoperative urine cultures. Though the 2005 guideline from Infectious Diseases Society of America recommends routine treatment of asymptomatic bacteriuria in patients undergoing urological procedures 24 , recent data from patients undergoing stone surgery have questioned the value of preoperative urine culture, as asymptomatic bacteriuria is a poor predictor of postoperative infection. 25 Furthermore, several studies have shown that treatment of asymptomatic bacteriuria in bladder cancer patients undergoing outpatient urological procedures (ie. cystoscopy and intravesical therapy) is unnecessary as these patients did not have an increased risk of UTI. 26, 27 A prospective trial on the utility of preoperative urine culture in patients undergoing RC is needed to fully address this issue.
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Diarrhea in the immediate postoperative period is a common phenomenon after urinary diversion, however for patients undergoing a continent urinary reservoir procedure, this is often a result of anatomic loss of the ileocecal valve along the alimentary tract. Since the most common trigger to test for CDI is diarrhea, we have found that less than half of our patients complaining of diarrhea had CDI. Despite appropriate hand hygiene and implementation of CDI preventive measures at our institution, our study still demonstrated an increased incidence of CDI. With the incidence of community-acquired CDI on the rise in recent years 3 , it is possible that some patients in our series are asymptomatic carriers of nontoxigenic Clostridium difficile. Whether treatment is necessary for an asymptomatic carrier of Clostridium difficile remains controversial. 28 One study has suggested that screening asymptomatic carriers at admission may lower in-hospital transmission rates of CDI. 29 Thus, a prospective study for screening of asymptomatic carriers of Clostridium difficile at the time of radical cystectomy is warranted.
The use of gastric acid reducers, such as histamine-2 antagonists or proton-pump inhibitors, has been suggested as a potential risk factor for the development of CDI. 28, 30 A potential mechanism is that a vegetative form of Clostridium difficile spores is sensitive to gastric acid and an elevated gastric pH facilitates passage of spores to the colon. 30 Our study also found that chronic antacid therapy was an independent risk factors for CDI within 90 days of RC (HR: 1.9, p=0.04). This result should be interpreted with caution as one potential confounder is that all patients were treated with perioperative antacids -especially in patients with prolonged nasogastric decompression. Nevertheless, in light of these findings, our institution has shifted away from giving patients perioperative antacids routinely since the completion of this study.
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The development of CDI in the postsurgical setting is associated with significant hospital morbidity and resource utilization. 6, 16 In a study assessing the outcomes of hospital acquired adverse events in radical cystectomy patients, Kim et al. found that patients with CDI had a longer hospital stay by 9 days, and an increase in total hospitalization cost by $21,000 compared to those without adverse events. 11 Similarly, our study found that CDI was associated with longer hospital stays, increased hospital-acquired infections, additional surgical and pharmacotherapies, and higher readmission rates. Based on these findings, it is fair to assume that CDI leads to longer stay or higher overall postoperative complication rates, but the development of CDI may also be a consequence of these factors. Therefore, it is difficult to identify a causality between CDI and postoperative complications with adequate certainty.
Several limitations of this study are noteworthy for discussion. This study was conducted at a high-volume tertiary referral center for bladder cancer so the findings may not be applicable to other settings. The increased incidence of CDI found in the present study may be a result of increased vigilance during the studied period or a reflection of increasing hospital-wide CDI occurrence. These findings highlight the need to identify the incidence of CDI in the preoperative setting. Additionally, RC in this study were performed by multiple experienced surgeons with different practice patterns and views regarding the use of perioperative antibiotics.
Such factors may have contributed to the high incidence of CDI, but we did not study the individual rates of CDI related to each surgeon. One major strength of the study is the detailed information available for each patient (ie. timing of preoperative, perioperative and postoperative antibiotics), which cannot be achieved by extracting data from large prospective databases. We recognize that outcomes related to CDI cannot be randomized, but a prospective trial involving multiple referral centers for bladder cancer may overcome the limitations of the current study.
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Conclusion
We found that the rate of CDI in patients undergoing RC and urinary diversion for bladder cancer is higher than previously reported. Additionally, the current study demonstrated that chronic antacid therapy and long duration of antibiotic exposure in the perioperative setting are independent predictors of CDI development in RC patients. Efforts focusing on minimizing antibiotic exposure in RC patients are needed and perioperative antimicrobial prophylaxis guidelines should be followed. These data also support future endeavors focusing on improving patient safety and reducing CDI in RC patients.
